Unlocking the Pharmacological Potential of Myricetin Against Various Pathogenesis
International Journal of Molecular Sciences · 28.04.2025 · 26 (9) · 4188
DOI: 10.3390/ijms26094188 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.04.2025. Verfasst von Saleh A Almatroodi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia. Hauptthemen laut MEDLINE: Flavonoids, Anti-Inflammatory Agents. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 236 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The researchers would like to thank the Deanship of Graduate Studies and Scientific Research at Qassim University for financial support (QU-APC-2025)., Deanship of Graduate Studies and Scientific Research Qassim University.
Abstract (Originalsprache)
Myricetin is a natural flavonoid with powerful antioxidant and anti-inflammatory potential commonly found in vegetables, fruits, nuts, and tea. The vital role of this flavonoid in the prevention and treatment of various diseases is evidenced by its ability to reduce inflammation and oxidative stress, maintain tissue architecture, and modulate cell signaling pathways. Thus, this review summarizes recent evidence on myricetin, focusing precisely on its mechanisms of action in various pathogenesis, including obesity, diabetes mellitus, arthritis, osteoporosis, liver, neuro, cardio, and reproductive system-associated pathogenesis. Moreover, it has been revealed that myricetin exhibits anti-microbial properties due to obstructive virulence factors, preventing biofilm formation and disrupting membrane integrity. Additionally, synergistic potential with other drugs and the role of myricetin-based nanoformulations in different diseases are properly discussed. This review seeks to increase the understanding of myricetin’s pharmacological potential in various diseases, principally highlighting its effective mechanisms of action. Further wide-ranging research, as well as more randomized and controlled clinical trial studies, should be executed to reconnoiter this compound’s therapeutic value, safety, and usefulness against various human pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia.
ORCID-Profile: Saleh A Almatroodi
Förderung
- The researchers would like to thank the Deanship of Graduate Studies and Scientific Research at Qassim University for financial support (QU-APC-2025).
- Deanship of Graduate Studies and Scientific Research Qassim University
Zitieren
APA
Almatroodi, S. A., & Rahmani, A. H. (2025). Unlocking the Pharmacological Potential of Myricetin Against Various Pathogenesis. International Journal of Molecular Sciences, 26(9), 4188. https://doi.org/10.3390/ijms26094188
Vancouver
Almatroodi SA, Rahmani AH. Unlocking the Pharmacological Potential of Myricetin Against Various Pathogenesis. International Journal of Molecular Sciences. 2025;26(9):4188. doi:10.3390/ijms26094188
BibTeX
@article{Almatroodi2025,
author = {Almatroodi, Saleh A and Rahmani, Arshad Husain},
title = {Unlocking the Pharmacological Potential of Myricetin Against Various Pathogenesis},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {9},
pages = {4188},
doi = {10.3390/ijms26094188}
}
EUVIMED